Abstract

Traditional drug discovery pipelines can require multiple years and billions of dollars of investment. Deep generative and discriminative models are widely adopted to assist in drug development. Classical machines cannot efficiently reproduce the atypical patterns of quantum computers, which may improve the quality of learned tasks. We propose a suite of quantum machine learning techniques: incorporating generative adversarial networks (GAN), convolutional neural networks (CNN) and variational auto-encoders (VAE) to generate small drug molecules, classify binding pockets in proteins, and generate large drug molecules, respectively.

Original languageEnglish (US)
Title of host publication2021 58th ACM/IEEE Design Automation Conference, DAC 2021
PublisherInstitute of Electrical and Electronics Engineers Inc.
Pages1356-1359
Number of pages4
ISBN (Electronic)9781665432740
DOIs
StatePublished - Dec 5 2021
Event58th ACM/IEEE Design Automation Conference, DAC 2021 - San Francisco, United States
Duration: Dec 5 2021Dec 9 2021

Publication series

NameProceedings - Design Automation Conference
Volume2021-December
ISSN (Print)0738-100X

Conference

Conference58th ACM/IEEE Design Automation Conference, DAC 2021
Country/TerritoryUnited States
CitySan Francisco
Period12/5/2112/9/21

All Science Journal Classification (ASJC) codes

  • Computer Science Applications
  • Control and Systems Engineering
  • Electrical and Electronic Engineering
  • Modeling and Simulation

Fingerprint

Dive into the research topics of 'Invited: Drug Discovery Approaches using Quantum Machine Learning'. Together they form a unique fingerprint.

Cite this